A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML... Read more about A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML...
A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML... Read more about A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML...
A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML... Read more about A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML...
A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML... Read more about A Randomized Phase 2/3 Study of DACOGEN (Decitabine) Plus JNJ-56022473 (Anti-CD123) Versus DACOGEN (Decitabine) Alone in Patients with AML...
Targeting MALT1 with the Small Molecule Inhibitor MI2 in Precursor B-Cell Acute Lymphoblastic Leukemia Read more about Targeting MALT1 with the Small Molecule Inhibitor MI2 in Precursor B-Cell Acute Lymphoblastic Leukemia
Estrogen Mediated Protection Against Stroke: Mitochodria as Subcellular Targets of Nitric Oxide Read more about Estrogen Mediated Protection Against Stroke: Mitochodria as Subcellular Targets of Nitric Oxide
Surface-Enhanced Dual-Frequency 2DIR Spectroscopy of Nanometer-Thick Layers at Interfaces Read more about Surface-Enhanced Dual-Frequency 2DIR Spectroscopy of Nanometer-Thick Layers at Interfaces
Development of an Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines Read more about Development of an Assay to Predict Efficacy of Ricin Toxin Subunit Vaccines
